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Abstract 
Osteopontin (OPN) is a secreted adhesive glycoprotein with a gly-arg-gly-asp-ser (GRGDS) cell binding domain. Several 
independent s udies have suggested that OPN functions in tumor growth and metastasis, and one likely possibility is that 
OPN facilitates tumor invasion by promoting tumor cell migration. Consistent with this hypothesis, immobilized OPN 
promoted concentration-dependent tumor cell migration (i.e., haptotaxis) in modified Boyden chambers. In particular, 
cleavage of OPN by thrombin, which likely occurs in the tumor microenvironment, resulted in enhancement of OPNs 
haptotactic activity; and assays performed with purified preparations of the two individual OPN thrombin-cleavage 
fragments demonstrated that all detectable activity was associated with the GRGDS-containing fragment. In contrast to the 
activity of both OPN and its GRGDS-containing fragment in promoting haptotaxis, neither of these proteins in solution 
promoted chemotaxis, indicating that each must be immobilized to promote cell migration. In haptotaxis assays, antibody 
LM609 to integrin ~ v133 blocked > 80% cell migration towards the GRGDS-containing OPN fragment, implicating o~ v~3 
as its principal functional receptor. In comparison with equimolar quantities of other adhesive proteins, the GRGDS-contain- 
ing OPN thrombin-cleavage fragment was not only > 2-fold more effective than intact OPN at promoting haptotaxis, but 
also > 8-fold and > 6-fold more effective than fibrinogen and vitronectin, respectively, indicating that this OPN fragment 
is highly active relative to other a v[33 ligands. 
Keywords: Haptotaxis; Chemotaxis; etvl33 Integrin; Fibrinogen; Vitronectin 
1. Introduction 
Tumor cell migration leads to tumor invasion and 
ultimately to the development of tumor metastases. 
Because cell migration is dependent on adhesive 
interactions with the extracellular matrix, matrix 
components at the tumor/host interface could be 
Abbreviations: BSA, bovine serum albumin; OPN, osteopon- 
tin. 
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important determinants of the rate of tumor cell 
migration into adjacent host tissue. In particular, 
ligands for the cell surface integrin av[33 may be 
especially significant in this process. For example, 
increased expression of Otv[33 correlates with 
melanoma vertical growth phase and metastasis [1-3] 
and with aggressive glioblastoma [4]. Moreover, 
melanoma cells selected for low expression of a v133 
were less tumorigenic than controls; and when a v[~3 
expression was restored by stable transfection, tu- 
morigenicity increased [5]. 
0167-4889/96/$15.00 Copyright © 1996 Elsevier Science B.V. All rights reserved. 
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One av[33 ligand which participates in adhesive 
interactions with tumor cells at the tumor/host inter- 
face is osteopontin (OPN), a secreted glycoprotein 
with a glycine-arginine-glycine-aspartate-serine 
(GRGDS) cell binding domain ([6]; reviewed in Ref. 
[7]). OPN is substantially overexpressed in a variety 
of experimental models of malignancy, and OPN 
expression correlates with the metastatic potential of 
transformed mouse cell lines [8-10]. Moreover, tu- 
mor cells transfected for expression of OPN antisense 
RNA exhibit a reduced ability to form tumors in vivo 
[11,12]. Analyses of human cancers have indicated 
that OPN is also highly overexpressed in a large 
variety of carcinomas, principally by host 
macrophages at the invasive edge of carcinomas aris- 
ing in the breast, lung and gastrointestinal tract, and 
by tumor cells and macrophages in carcinomas of the 
kidney and endometrium [13]. Consistent with over- 
expression of OPN in tumors, the concentrations of
OPN in the blood plasma of patients with metastatic 
cancer are substantially elevated in comparison with 
the low levels that normally circulate [14]. 
OPN promotes attachment and spreading of a vari- 
ety of cell types including tumor cells [15-17] pri- 
marily through interactions with a v [53 [ 18,19]; how- 
ever, interactions with O~v[31 and ~v[35 also con- 
tribute [20,21]. Although the native form of OPN is 
active in cell attachment assays, thrombin-cleavage of 
OPN results in substantial enhancement of its adhe- 
sive activity [19]. This cleavage occurs within six 
amino acid residues of the GRGDS sequence [9,22], 
raising the interesting possibility that thrombin-clea- 
vage further activates OPN by allowing greater ac- 
cessibility of the GRGDS domain to cell surface 
receptors. Moreover, thrombin cleaves the OPN pre- 
sent in blood plasma during the natural course of 
blood coagulation, suggesting that thrombin-cleavage 
of OPN occurs in vivo wherever OPN is present and 
the blood coagulation pathway is activated [14]. In 
particular, such cleavage likely occurs in tumors 
where the presence of active thrombin is indicated by 
the deposition of cross-linked fibrin (reviewed in 
Refs. [23,24]). 
Thus the collective vidence indicates that OPN is 
an important element of tumor extracellular matrix 
and that this protein functions in cell adhesion at the 
tumor/host interface where it could influence tumor 
invasion. Moreover, enhancement of OPNs adhesive 
properties by thrombin-cleavage suggested that 
thrombin may be important in regulating OPN func- 
tion in cell migration. Therefore, to investigate OPN 
activity in promoting tumor cell migration and its 
regulation by thrombin-cleavage, we tested OPN, 
unfractionated thrombin-cleaved OPN, and purified 
preparations of the two individual OPN thrombin- 
cleavage fragments in quantitative cell migration as- 
says. In particular, these studies identified the N- 
terminal GRGDS-containing OPN thrombin-cleavage 
fragment as an O~v[33 ligand which, in comparison 
with intact OPN, fibrinogen, and vitronectin, is highly 
active in promoting tumor cell migration. 
2. Materials and methods 
2.1. Purification of OPN and OPN thrombin-clea- 
rage fragments 
Human OPN was purified from breast milk as 
described previously [19], and purified OPN was 
cleaved with purified thrombin (Sigma Chemicals, St. 
Louis, MO) to yield two polypeptide fragments of 
similar size [22]. Cleaved OPN (2 mg) was diluted 
with 15 volumes of buffer A (0.02 M Tris pH 8.0, 
0.01 M NaC1) and applied to a DEAE 5PW Protein- 
Pak high pressure liquid chromatography column 
(Millipore/Waters Associates, Milford, MA) at 1 
ml/min.  After loading, the column was washed with 
buffer A and bound fragments eluted with the follow- 
ing series of linear gradients at a flow rate of 1 
ml/min:  time zero, 100% buffer A; t = 25 min, 75% 
buffer A, 25% buffer B (0.02 M Tris pH 8.0, 1.0 M 
NaC1); t = 75 min, 50% buffer A, 50% buffer B; 
t = 100 rain, 100% buffer B. One-ml fractions were 
collected and aliquots were subjected to immuno- 
blotting with two different peptide antisera, one of 
which was raised to a peptide sequence uniquely 
present in the N-temlinal thrombin-cleavage fragment 
of human OPN and the other which was raised to a 
peptide representing a unique sequence present in the 
C-terminal fragment (see below for description of 
antibodies). Fractions containing the N-terminal or 
C-terminal fragments were initially identified by 
staining with these antibodies. The C-terminal frag- 
ment eluted first as a peak centered at fractions #35 
and 36 and the N-terminal fragment eluted second as 
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a peak centered at fractions #36-39. Despite the 
partial overlap of the elution profiles, individually 
purified fragment preparations were obtained from 
the earlier and later portions of the C-terminal frag- 
ment and N-terminal fragment elution peaks, respec- 
tively. The identity and purity of both fragment 
preparations were established independently with N- 
terminal amino acid sequence analyses (residues #1- 
5) and SDS PAGE [25]. The N-terminal fragment did 
not stain significantly with Coomassie blue, but this 
fragment was visualized readily with a copper stain 
procedure (Bio-Rad Laboratories, Hercules, CA). 
2.2. Cell lines and cell migration assays 
Cell lines were obtained from the American Type 
Culture Collection (Rockville, MD). They were main- 
tained in Dulbecco's modified Eagle's medium 
(DMEM) containing 10% fetal calf serum. Prior to 
assay, cells were harvested with brief trypsinization 
(0.05% trypsin, 0.5 mM EDTA), in Hanks' balanced 
salt solution without divalent cations. Cells then were 
washed twice with serum-free DMEM and resus- 
pended in serum-free DMEM containing 10 mg/ml  
bovine serum albumin (BSA, Sigma Chemicals). 
Cell migration was assayed with 8-micron pore 
size Transwell migration chambers (Costar Corp., 
Cambridge, MA) [26,27]. For haptotaxis assays, the 
undersides of membranes were coated at room tem- 
perature with OPN, OPN thrombin-cleavage frag- 
ments, fibrinogen, or vitronectin, as indicated. OPN 
and OPN fragments were purified as described above. 
Human vitronectin was purchased from Gibco- 
BRL/Life Technologies (Gaithersburg, MD) and 
Collaborative Biomedical Products (Bedford, MA). 
Vitronectin from both sources gave equivalent re- 
suits. Human fibrinogen was purchased from Cal- 
biochem (La Jolla, CA) and any contaminating fi-
bronectin was removed by adsorption to gelatin cou- 
pled to cross-linked agarose beads (Sigma Chemical, 
St. Louis, MD) [28]. After 60 min, the protein coating 
solutions were removed and remaining protein bind- 
ing sites on the undersides of the membranes were 
blocked by incubation with a solution of 100 mg/ml  
BSA at room temperature for 60 min; membranes 
next were washed with DMEM. To quantitate bind- 
ing of the different proteins to the membranes, 
aliquots of each were radiolabeled with [1251] using 
the iodobead method (Pierce Chemicals, Rockford, 
IL) and binding efficiencies calculated as the ratio of 
bound dpm to total dpm applied. 
In assays designed to compare native OPN with 
thrombin-cleaved OPN, the undersides of membranes 
were coated sequentially with OPN and BSA; where 
indicated, the bound OPN then was cleaved in situ by 
incubating the underside of each membrane with 1 
unit of thrombin. As determined with polyacrylamide 
gel electrophoresis and autoradiography of radiola- 
beled OPN tracer extracted from such membranes, 
thrombin-cleavage was ~ 60% complete with this 
method. After incubation with thrombin, membranes 
were washed extensively with DMEM. No thrombin 
was detected after washing as determined with the 
Kabi $2238 chromogenic substrate assay which de- 
tects thrombin at concentrations a low as 10 pM 
(Kabi Pharmacia Diagnostics, Piscataway, NJ). How- 
ever, as an additional control, we included in several 
experiments he irreversible thrombin inhibitor D-phe- 
L-pro-L-arg-CH2C1 (PPACK, Calbiochem). Thus for 
membranes treated with 1 unit of thrombin we subse- 
quently added 2 txg of PPACK which, as determined 
with the Kabi substrate assay, was a 25-fold excess of 
inhibitor. 
After membranes were prepared as outlined above, 
1 × 105 cells were added to the upper chambers in 
serum-free DMEM containing 10 mg/ml  BSA. Cell 
migration was allowed to proceed at 37°C in a stan- 
dard tissue culture incubator for the indicated inter- 
vals of time; cells then were removed from the upper 
side of the membrane with a cotton swab, and cells 
that migrated to the undersides were stained with 
0.2% crystal violet in 2% ethanol followed by a brief 
rinse in distilled water. Dried membranes were cut 
out and mounted on glass slides in immersion oil. At 
least 10 random high power fields from each of 
triplicate membranes were counted for each experi- 
mental condition. No cell migration was observed 
when membrane filters were coated with BSA alone, 
and in no cases did we observe cells in the lower 
chamber which had traversed the membranes but did 
not remain attached. 
To investigate chemotaxis promoted by soluble 
OPN and soluble OPN thrombin-cleavage fragments, 
membranes were prepared by coating undersides with 
100 Ixg/ml gelatin (Sigma Chemical) followed by 
100 mg/ml  BSA to block remaining protein binding 
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sites. Soluble OPN or OPN fragment was added to 
the lower chambers at the indicated concentrations 
together with 10 mg/ml  BSA. Under these condi- 
tions, OPN and OPN fragments in the lower cham- 
bers were prevented from binding to the membranes 
so that chemoattractant c ivity, as opposed to hapto- 
tactic activity, could be assayed. 
2.3. Antibodies to osteopontin and integrins 
Affinity-purified rabbit IgG to a 20 amino acid 
synthetic peptide representing the GRGDS region of 
human OPN was prepared as described previously 
[19]. The peptide antigen used to derive this antibody 
had the following sequence: 
VPTVDTYDGRGDSVVYGLR (C), with cysteine 
added for conjugation to keyhole limpet hemocyanin. 
This sequence is present in the N-terminal thrombin- 
cleavage fragment, and antibody derived from immu- 
nization with this peptide bound to the N-terminal but 
not the C-terminal fragment. Antibody to the C- 
terminal thrombin-cleavage fragment of human OPN 
was prepared by immunizing rabbits with the follow- 
ing peptide, also conjugated to keyhole limpet hemo- 
cyanin: (C) DPKSKEEDKHLKFRISHE. As ex- 
pected, this antibody bound the C-terminal but not 
the N-terminal thrombin-cleavage fragment, and it 
also bound intact OPN. A similar antibody to a rat 
OPN synthetic peptide has been described previously 
[29]. Control rabbit IgG was purified with protein A 
Sepharose (Pharmacia). 
a v[33 Monoclonal antibody LM 609 ascites [30] 
was kindly provided by Dr. David Cheresh, Scripps 
Clinic and Research Foundation, La Jolla, CA. Mouse 
monoclonal anti-131 integrin (P4C10) and anti-OLv[35 
integrin (P1F6) ascites were purchased from Gibco- 
BRL/Life Technologies. Each monoclonal antibody 
was purified with the Affigel protein A MAPS II kit 
(Bio-Rad Laboratories). Control mouse IgG was pur- 
chased from Sigma and re-purified according to the 
same procedure. 
3. Results 
To assay OPN activity in promoting tumor cell 
migration, cell migration assays were performed with 
modified Boyden chambers (Transwell motility 
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Fig. 1. Tumor cell haptotaxis through filters coated with increas- 
ing concentrations of OPN (dashed lines) in comparison with 
migration through filters coated with OPN which was subse- 
quently cleaved by thrombin in situ (solid lines) (see Section 2). 
After coating with OPN, all filters were incubated with 100 
mg/ml BSA to block remaining protein binding sites; and fol- 
lowing incubation with thrombin, filters were washed extensively 
to eliminate all detectable thrombin (see text). Assays were 
terminated at 5 h; each point represents the mean+S.D, of 
triplicates. 
chambers, Costar Corp.) in which the undersides of 
the membranes were coated with graded concentra- 
tions of OPN. Such assays measure haptotaxis, i.e., 
cell migration in a gradient of bound ligand [26], and 
as shown in Fig. 1, OPN promoted haptotaxis of 
human T24 bladder carcinoma cells and MDA-MB- 
435s breast carcinoma cells. Membranes coated with 
increasing concentrations of OPN were correspond- 
ingly more active in promoting cell migration, up to a 
coating concentration f ~ 10 Ixg/ml, at which max- 
imal activity was observed. 
In parallel, haptotaxis assays with thrombin- 
cleaved OPN were performed to test the conse- 
quences of cleavage of OPN by thrombin for directed 
tumor cell migration. For these experiments, OPN 
was first bound to the membranes and then cleaved 
by thrombin in situ as described in Section 2. Upon 
cleavage, OPN was more active at promoting tumor 
cell haptotaxis and this increase in functional activity 
was evident at all protein concentrations tested (Fig. 
1). Moreover, in similar experiments designed to 
follow the time course of tumor cell haptotaxis over 
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Fig. 2. Time course of T24 cell haptotaxis through filters coated 
with 20 Ixg/ml OPN (dashed line) in comparison with identically 
coated filters which were subsequently incubated with thrombin 
to cleave OPN in situ (solid line). Each point represents the 
mean + S.D. from triplicate assays. 
treatment of thrombin with PPACK blocked the en- 
hancement, demonstrating that the enzymatic activity 
of thrombin was required. Because PPACK is a 
specific thrombin inhibitor, these experiments also 
established that enhancement was not attributable to 
any contaminating proteases which might be present. 
Finally, and also shown in Fig. 3, membranes coated 
with thrombin at the concentration used for cleavage 
of bound OPN did not promote any cell migration. 
Thrombin cleaves an arginyl-serine peptide bond 
in OPN thus generating two fragments of very similar 
size, one of which contains the GRGDS sequence just 
six residues from its carboxyterminus and another 
which lacks a GRGDS sequence [9,22]. To purify the 
individual fragments for functional characterization, 
we developed a purification scheme employing an- 
ion-exchange high pressure liquid chromatography. 
Identification of column fractions consisting of puri- 
fied N-terminal or C-terminal fragment was facili- 
tated by antibodies pecific for each (see Section 2), 
and confirmation was independently obtained with 
24 h, thrombin-cleaved OPN promoted a greater ate 
of tumor cell migration throughout this interval (Fig. 
2). Significantly, the enJhanced activity of thrombin- 
cleaved OPN relative to intact OPN illustrated in 
Figs. 1 and 2 is an underestimate b cause thrombin- 
cleavage of filter-bound OPN was ~ 60% efficient 
(see Section 2). 
Several control experiments were performed to 
establish that the enhanced activity of OPN following 
cleavage by thrombin was a direct consequence of 
structural changes in OPN mediated by the enzymatic 
activity of thrombin mad that it was not due to 
differences in efficiencies of protein binding to the 
membranes or to thrombin contamination of the 
membranes. First, as determined with [125I]-labeled 
tracers, intact and thrombin-cleaved OPNs bound to 
the migration chamber membranes with equal effi- 
ciency. Second, as determined with sensitive throm- 
bin substrate assays (see Section 2), no thrombin 
remained after washing the membrane filters that had 
been treated with thrombin to cleave bound OPN in 
situ. Furthermore, and as shown in Fig. 3, post-treat- 
ment of membranes with a molar excess of PPACK, 
which is a highly specific and irreversible thrombin 
inhibitor [31], was without effect. In contrast, pre- 
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Fig. 3. T24 cell haptotaxis. The undersides of migration chamber 
filters were coated with OPN (10 ixg/ml) followed by BSA (100 
mg/ml) to block remaining protein binding sites. Subsequently, 
some filters were incubated with thrombin (OPN+THR) to 
cleave OPN in situ, others were incubated with thrombin and 
then with a molar excess of the thrombin inhibitor PPACK 
(OPN + THR-PPACK), and others were incubated with thrombin 
together with PPACK (OPN+PPACK-THR) (see Section 2). 
Migration assays were terminated after 5 h; each bar represents 
the mean + S.D. from triplicates. Note that inclusion of PPACK 
in the thrombin incubation prevented enhancement of OPN mi- 
gration promoting activity but that filters treated with thrombin 
followed by PPACK promoted the same increase in haptotaxis 
observed on identical filters not treated with PPACK. Also, filters 
coated with thrombin (THR) followed by BSA did not promote 
any haptotaxis nor did filters coated with BSA alone. 
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lows: intact OPN (13.8%), C-terminal fragment 
(12.6%), N-terminal fragment (11.2%). Next, the cell 
migration data were plotted as a function of pico- 
moles ligand bound to the membranes, taking into 
account he minor differences in binding efficiencies 
as well as the differences in molecular weight (~ 
70000 for OPN; ~ 35 000 for each fragment). As 
shown in Fig. 5 (bottom panel), these experiments 
indicated that the N-terminal fragment is nearly 3-fold 
more active than intact OPN on a molar basis. 
Fig. 4. SDS PAGE with 8.5% (w/v) acrylamide of intact OPN 
(10 Ixg) and the two fragments generated from OPN by thrombin 
cleavage (10 txg each). In contrast to intact OPN and the 
C-terminal fragment, the N-terminal GRGDS-containing frag- 
ment did not stain significantly with Coomassie blue R-250, but 
it was visible with a copper staining procedure (see text). Molec- 
ular weight standards included rabbit phosphorylase b (94 kDa), 
bovine serum albumin (67 kDa), chick ovalbumin (43 kDa), and 
bovine carbonic anhydrase (30 kDa). 
N-terminal sequence analysis of purified protein. As 
shown in Fig. 4, SDS PAGE indicated that the two 
purified fragments have very similar electrophoretic 
mobilities, as expected, corresponding to M r ~ 
35 000. The C-terminal fragment stained readily with 
Coomassie blue, but, in contrast, the N-terminal frag- 
ment did not bind this dye significantly. Instead, the 
N-terminal fragment was visualized with a copper 
staining procedure [32]. 
Next, the purified OPN thrombin-cleavage frag- 
ments were subjected to analyses in haptotaxis as- 
says. Data presented in Fig. 5 (top panel) relate the 
comparative cell migration promoting activities of 
membranes coated with increasingly concentrated so- 
lutions of intact OPN and each of the two purified 
fragments. These data indicate that no detectable 
activity is associated with the C-terminal fragment 
and that the N-terminal fragment, similar to unfrac- 
tionated thrombin-cleaved OPN, is more active than 
intact OPN. To control for any differences in effi- 
ciencies of binding to the membranes, we labeled 
intact OPN and both fragments with [125I] and deter- 
mined binding efficiencies at each of the concentra- 
tions employed. For example, at a protein concentra- 
tion of 10 Ixg/ml, binding efficiencies were as fol- 
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Fig. 5. Top panel: T24 cell haptotaxis (5 h) promoted by mem- 
branes coated with increasing quantities of intact OPN, and the 
two individual fragments generated from OPN by thrombin- 
cleavage. In contrast o the N-terminal GRGDS-containing frag- 
ment, no activity was found in association with the C-terminal 
fragment. Bottom panel: Haptotaxis, as in top panel but ex- 
pressed as a function of picomoles ligand bound to the mem- 
brane. Efficiencies of ligand binding were determined with 
[125I]-labeled tracers (see text). Data are presented as the mean_ 
S.D. from triplicate assays; absence of error bars indicates that 
S.D. was less than the diameter of the circles used to represent 
the data points. 
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Absence of detectable., activity associated with the 
C-terminal fragment was consistent with findings 
made in independent experiments performed with 
affinity-purified rabbit antibody raised to a 20 amino 
acid synthetic peptide containing the GRGDS region 
of human OPN (see Section 2). This antibody, which 
binds the N-terminal fragment but not the C-terminal 
fragment, blocked > 90% of T24 cell migration and 
> 85% MDA-MB-435s cell migration towards filters 
coated with 20 txg/ml unfractionated thrombin- 
cleaved OPN. Control antibody at the same concen- 
tration (10 txg/ml) had no effect. In addition, we 
performed experiments o test the possibility that the 
C-terminal fragment interferes with haptotaxis to- 
wards the active N-terminal fragment. However, 
membranes coated with solutions of 10 ixg/ml N- 
terminal fragment together with 10 txg/ml C-termi- 
nal fragment promoted cell migration identically to 
membranes coated with 10 ixg/ml N-terminal frag- 
ment alone, indicating that the C-terminal fragment 
lacks inhibitory activity. 
To test the involvement of OLv[33 in haptotaxis 
towards the purified N-terminal thrombin-cleavage 
fragment of OPN, we performed cell migration as- 
says, as in Fig. 5, but in the presence of 10 ixg/ml 
a v~ 3 antibody LM609 [30]. This antibody inhibited 
> 90% T24 haptotaxis and > 80% MDA-MB-435s 
haptotaxis on filters coated with 20 Ixg/ml of the 
N-terminal OPN fragment; and neither control anti- 
body nor OLv[35 P1F6 antibody had any effect, indi- 
cating that O~vl33 is the principal receptor on these 
cells which functions in cell migration towards this 
OPN fragment. In control experiments, CXvl33 anti- 
body LM609 did not inhibit migration of either of 
these cell lines towards filters coated with laminin, 
establishing the specificity of LM609 antibody inhibi- 
tion of cell migration towards the N-terminal OPN 
fragment. For both cell '.lines, e~v[33 antibody LM609 
also inhibited nearly all (~ 95%) haptotaxis towards 
intact OPN. 
Cell migration assays, also were performed to in- 
vestigate whether the N-terminal OPN fragment was 
not only more active than intact OPN but also more 
active than other o~ v[33 ligands. As shown in Fig. 6A, 
membranes coated with increasingly concentrated so- 
lutions of the N-terminal OPN fragment promoted 
greater cell migration tlhan membranes coated with 
corresponding concentrations of fibrinogen. To com- 
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Fig. 6. Panels A: Tumor cell haptotaxis (5 h) promoted by 
membranes coated with increasing quantifies of fibrinogen in 
comparison with membranes coated with increasing quantities of 
the N-terminal GRGDS-contalning OPN thrombin-cleavage frag- 
ment. Each point represents the mean + S.D. from triplicate as- 
says. Panels B: Data presented inPanels A replotted as a function 
of picomoles of ligand bound to the membrane, taking into 
account molecular weights of the ligands (fibrinogen =341000; 
N-terminal OPN fragment =35 000) and efficiencies of binding 
of each to the membrane ( .g., at a concentration f 10 p,g/ml 
44.3% fibrinogen bound and 11.2% N-terminal OPN fragment 
bound). 
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Fig. 7. Panels A: Tumor cell haptotaxis (5 h) promoted by 
membranes coated with increasing quantitites of vitronectin in 
comparison with increasing quantitites of the N-terminal OPN 
thrombin-cleavage fragment. To eliminate possible interactions 
between these ligands and integrins av131 or OLv135, assays were 
performed in the presence of 131 and av135 blocking antibodies 
(see text). However, similar results were obtained in the absence 
of these antibodies, indicating that 131 and o~ v135 integrins do not 
function significantly in the migration of these cell lines towards 
either ligand. Data points represent the mean___ S.D. of triplicate 
assays. Panels B: Data presented in Panels A replotted as a 
function of picomoles ligand bound to the membrane (average M r 
vitronectin= 70000; at a concentration of 10 ixg/ml, 36.7% 
vitronectin bound). 
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Fig. 8. Assay of soluble OPN and the N-terminal GRGDS-con- 
taining OPN thrombin-cleavage fragment for chemoattractant 
activity. T24 cell migration assays were performed with cham- 
bers in which the undersides of the membranes were coated first 
with gelatin, followed with BSA to block remaining protein sites 
(see Section 2). To test for chemotaxis, oluble OPN or N-termi- 
nal OPN fragment was included in the lower chambers at the 
concentrations indicated. Assays were terminated after 5 h; data 
are presented as the mean+ S.D. from triplicate assays. In all 
cases, cell migration appeared to be independent of soluble OPN 
concentration i the lower chamber; i.e., there was no evidence 
of chemoattractant c ivity. 
pare relative activities of the N-terminal OPN frag- 
ment and fibrinogen as a function of picomoles lig- 
and bound to the membrane, we replotted the data, 
taking into account the binding efficiencies of each 
ligand to the membrane, and found that the N-termi- 
nal fragment was greater than 8-fold more active than 
fibrinogen on a molar basis (Fig. 6B). Similarly, we 
found that the N-terminal OPN fragment was consid- 
erably more active than vitronectin, which is a ligand 
not only for eL vl33 but also for e~vl3 ] [33] and OLvl35 
[34]. Therefore, to compare the activities of the N- 
terminal OPN fragment and vitronectin in promoting 
cell migration, specifically as they relate to OLvB 3 
function in the absence of contributions by (x v[3~ or 
oLvl35 integrins, cell migration assays were also per- 
formed with 10 Ixg /ml  each of a 13j-blocking mono- 
clonal antibody (P4C10) together with a v135-block- 
ing monoclonal antibody (P1F6). As shown in Fig. 7, 
under these conditions the N-terminal OPN fragment 
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was greater than 6-fold more active than vitronectin 
on a molar basis. 
Finally, assays were designed to test the possibility 
that OPN or its N-terrrfinal fragment also promote 
chemotaxis, i.e., cell migration in a gradient of solu- 
ble ligand. To distinguish unambiguously the promo- 
tion of chemotaxis by soluble OPN from the promo- 
tion of haptotaxis by irmnobilized OPN, it was essen- 
tial to carry out migration assays under conditions 
such that OPN included in the lower chambers was 
prevented from binding to the undersides of the 
membranes. This required blocking of all protein 
binding sites on the undersides of membranes prior to 
assay with a high concentration f BSA (see Section 
2). However, because blocking of protein binding 
sites with BSA alone would preclude cell migration 
due to elimination of al]L cell attachment sites on the 
undersides of membranes, we tested soluble OPN for 
promotion of chemotaxis n experiments in which the 
undersides of membranes were coated first with an 
adhesive ligand (gelatin) followed by blocking of the 
remaining protein binding sites with BSA. As shown 
in Fig. 8, cells migrated through these membranes; 
however, neither soluble OPN nor soluble N-terminal 
OPN fragment enhanced migration, indicating the 
absence of chemoattractant activity. Moreover, we 
found no evidence of chemoattractant c ivity associ- 
ated with the C-terminal OPN fragment. In related 
experiments we also tested the possibility that soluble 
ligand in the lower chamber could promote chemo- 
taxis of cells in chambers with membranes to which 
OPN had been immobilized. For these purposes, the 
undersides of membranes were coated first with a 
concentration of OPN (5 p,g/ml) which was previ- 
ously determined to be suboptimal for cell migration 
(see Fig. 1). Remaining protein binding sites then 
were blocked with BSA. Chemotaxis assays were 
performed as in Fig. 8, and we again found no 
evidence of chemoattractant c ivity. 
4. Discussion 
Data presented here demonstrated that a gradient 
of immobilized OPN promotes cell migration, i.e., 
haptotaxis, and that cell migration is dependent on 
OPN concentration. In particular, we found that 
cleavage of OPN by thrombin increased OPN activity 
in promoting haptotaxis. Enhanced activity of throm- 
bin-cleaved OPN in comparison with intact OPN was 
observed at all protein concentrations tested; and in 
experiments designed to study haptotaxis as a func- 
tion of time, thrombin-cleaved OPN was found to 
promote a 2- to 3-fold increase in cell migration 
throughout a 24-h interval. Control experiments es- 
tablished that the observed ifference in relative ac- 
tivities of the intact and thrombin-cleaved OPNs was 
a direct consequence of enzymatic leavage of OPN 
by thrombin and that it was not due to binding of 
thrombin to the membranes. Moreover, membranes 
coated with thrombin alone did not promote any cell 
migration. 
Previously, analyses of N-terminal amino acid se- 
quences derived from unfractionated thrombin- 
cleaved OPNs in comparison with OPN cDNA se- 
quences established that the thrombin-cleavage site is 
present six amino acid residues carboxyterminal to
the GRGDS sequence in both human and rat OPNs 
[9,22]. Electrophoretic analyses performed under 
non-denaturing conditions indicated that the two OPN 
fragments generated by thrombin cleavage do not 
remain associated [19], however, neither of these 
fragments had been isolated previously. Therefore, to 
analyze the activities of each of these two fragments 
apart from the other, we devised a protocol which 
yields purified preparations of each of the individual 
fragments. Next, we tested the purified fragment 
preparations in haptotaxis assays and found that only 
the N-terminal fragment had detectable activity and 
that on a molar basis, the N-terminal fragment was 
nearly 3-fold more active than intact OPN. Thus, 
these experiments indicated that the N-terminal, 
GRGDS-containing fragment is responsible for the 
enhanced activity associated with unfractionated 
thrombin-cleaved OPN. Consistent with these find- 
ings, antibody raised to a 20 amino acid synthetic 
peptide containing the GRGDS sequence, which binds 
the N-terminal OPN thrombin-cleavage fragment, 
blocked > 85% cell migration towards unfraction- 
ated thrombin-cleaved OPN. 
Enzymatic digestion of OPN by thrombin also 
enhances OPN activity in promoting cell attachment 
and spreading [19]; however, it is likely that in- 
creased activity of thrombin-cleaved OPN in promot- 
ing cell migration is of greater significance, particu- 
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larly in tumors. OPN is overexpressed in a variety of 
cancers - by tumor cells and invading host 
macrophages in some tumors, and predominantly by 
invading host macrophages in others. Such overex- 
pression is especially pronounced at the edge of 
tumors (i.e., the tumor/stroma interface) and in areas 
of tumor necrosis [13]. Moreover, fibrin is often 
found particularly at the tumor periphery [24], indi- 
cating that the coagulation pathway is active where 
OPN is most abundant. The presence of fibrin in 
association with tumors is a consequence of the 
hyperpermeability of the tumor-associated vascula- 
ture; this hyperpermeability allows for extravasation 
of fibrinogen and blood clotting factors, resulting in 
activation of the extrinsic clotting pathway with gen- 
eration of thrombin and fibrin [23,35]. Consequently, 
it is highly probable that OPN associated with tumors 
is cleaved by thrombin, resulting in enhancement of
OPN migration promoting activity at the tumor/host 
interface precisely where tumor invasion proceeds. 
Enhancement of OPN haptotactic activity as a 
consequence of thrombin-cleavage is most probably 
relevant o cell types in addition to those tested here, 
and we are currently investigating this possibility. 
Thus it is also likely that thrombin regulation of OPN 
function is significant for cell migration in patholo- 
gies other than cancer and that such regulation occurs 
wherever OPN is expressed and the blood coagula- 
tion pathway is activated. Probable examples include 
atherosclerotic lesions [36-38], sites of myocardial 
infarction [39], glomerulonephritis [40], and a variety 
of other inflammatory conditions [41 ]. 
Previously, others have reported that soluble OPN 
promotes chemotaxis of vascular smooth muscle cells 
[18,42]; however, in this study we found no evidence 
that OPN has chemoattractant activity. Rather, our 
experiments indicated that OPN must be immobilized 
to promote cell migration. There are several possible 
explanations for the apparent discrepancies between 
our findings and previous reports. For one, vascular 
smooth muscle cells may respond differently than 
tumor cells to soluble OPN. Alternatively, and be- 
cause protocols involving migration assays with vas- 
cular smooth muscle cells did not include steps de- 
signed to block all protein binding sites on the under- 
sides of membranes prior to assay, soluble OPN 
included in the lower chambers of such experiments 
may have bound to the membranes, thus providing a 
gradient of bound OPN. By contrast, our protocols 
for chemotaxis assays included blocking of remaining 
protein sites on the undersides of membranes with a 
high concentration of BSA (100 mg/ml) .  With our 
conditions, soluble OPN in the lower chamber was 
unable to bind, and in these experiments no chemo- 
taxis was observed. 
Our findings that immobilization of OPN is re- 
quired for promotion of tumor cell migration in vitro 
suggest hat OPN must also be immobilized in vivo 
for it to participate in promoting of tumor cell inva- 
sion. However, there is good evidence that immobi- 
lization of OPN does occur particularly through 
transglutaminase catalyzed covalent cross-linking 
[43], of either multiple OPN molecules to form high 
molecular weight OPN aggregates or to fibronectin to 
form OPN/fibronectin complexes [44]. In addition, 
high molecular weight OPN complexes have been 
demonstrated to exist in vivo [16,45]. Interestingly, 
the amino acid residues present in OPN which partic- 
ipate in tranglutaminase catalyzed cross-linking have 
be identified in a region near the N-terminus of the 
native molecule [45], and therefore these sites are 
also present in the active thrombin-cleavage fragment 
which contains the GRGDS cell binding region. 
Finally, we investigated the involvement of the 
~v[~3 integrin in mediating haptotaxis towards the 
GRGDS-containing thrombin-cleavage fragment of 
OPN and the activity of this OPN fragment relative 
to other av[33 ligands. We had shown previously 
with affinity chromatography and cell attachment 
assays that av[33 is the principal receptor which 
binds to native OPN as well as to unfractionated, 
thrombin-cleaved OPN [19,46]. Consequently, it was 
not surprising that the LM609 monoclonal antibody 
to OL v133 nearly abolished T24 bladder carcinoma nd 
MDA-MB-435s breast carcinoma cell migration to- 
wards the active OPN fragment as well as towards 
intact OPN. Of particular significance, however, the 
GRGDS-containing OPN fragment was on a molar 
basis > 8-fold more active than fibrinogen, > 6-fold 
more active than vitronectin, and > 3-fold more 
active than intact OPN. Collectively, these data indi- 
cate that the GRGDS-containing OPN thrombin- 
cleavage fragment is an OLv[33 ligand which is espe- 
cially potent in promoting tumor cell migration in 
vitro, thereby predicting that it is also particularly 
active in promoting tumor cell invasion in vivo. 
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Moreover, these data illustrate a potentially important 
mechanism by which activation of the blood coagula- 
tion pathway in the vicinity of OPN expression, as it 
probably occurs in cancer and other pathologies, can 
lead to substantial enhancement of cell migration. 
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